WG
ABBV icon

Wellington Group’s AbbVie ABBV Stock Holding History

Wellington Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Sell
1,507
-110
-7% -$23.7K 0.1% 124
2026
Q1 		$352K Sell
1,617
-88
-5% -$19.5K 0.11% 121
2025
Q4 		$390K Buy
+1,705
New +$388K 0.13% 103

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Group's ABBV Position: Q2 2026 in Review

Wellington Group reduced its AbbVie (ABBV) stake by 6.8% in Q2 2026, selling an estimated $23.7K and leaving 1,507 shares worth $379K. The position accounts for 0.1% of the portfolio, ranked #124.

Wellington Group first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $390K in Q4 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wellington Group held 1,507 shares of AbbVie worth $379K as of Q2 2026.
  • Wellington Group sold 110 AbbVie shares in Q2 2026, an estimated $23.7K.
  • AbbVie made up 0.1% of Wellington Group's portfolio in Q2 2026, its #124 holding.
  • Wellington Group first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Wellington Group's AbbVie position peaked at $390K in Q4 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.